Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jcin.2019.02.026 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Solysafe Device Pushed Away by Amplatzer Septal Occluder After Closure of a Residual Atrial Septal Defect.
JACC Cardiovasc Interv
June 2019
Department of Pediatric Cardiology, Stuttgart Hospital, Stuttgart, Germany.
Mid-term results of Solysafe® septal occluder for percutaneous closure of secundum atrial septal defects.
Turk Gogus Kalp Damar Cerrahisi Derg
January 2018
Department of Pediatric Cardiology, Private, İzmir, Türkiye.
Background: In this article, we report mid-term follow-up results of the Solysafe® septal occluder for percutaneous closure of secundum atrial septal defects.
Methods: A total of 25 patients (8 males, 17 females; mean age 8.4±3.
Long-term follow-up of interventional closure of atrial septal defect using the Solysafe™ Septal Occluder.
Int J Cardiol
November 2016
Pediatric Cardiology, University Children's Hospital, Pediatric Heart Center, Zurich, Switzerland; Congenital Cardiovascular Surgery, University Children's Hospital, Pediatric Heart Center, Zurich, Switzerland.
Wire fractures in Solysafe septal occluders: a single center experience.
Catheter Cardiovasc Interv
June 2012
Department of Cardiology, University of Leipzig, Leipzig, Germany.
Objectives: To determine the incidence of device fractures (DF) after implantation of a Solysafe Septal Occluder (iSSO) and to assess the spectrum of associated problems.
Background: In August 2010, after initial unpublished reports on DF, the manufacturer issued an "urgent field safety notice," prompting all medical care providers to re-examine all patients after iSSO.
Methods: Prospective single center study.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!